Article
Evidence for activation of mutated p53 by apigenin in human pancreatic cancer.
Biochimica et biophysica acta - 1 Feb 2012
King Jonathan C, Lu Qing-Yi, Li Gang, Moro Aune, Takahashi Hiroki, Chen Monica, Go Vay Liang W, Reber Howard A, Eibl Guido, Hines O Joe
Abstract excerpt
Pancreatic cancer is an exceedingly lethal disease with a five-year survival that ranks among the lowest of gastrointestinal malignancies. Part of its lethality is attributable to a generally poor response to existing chemotherapeutic regimens. New therapeutic approaches are urgently needed. We aimed to elucidate the anti-neoplastic mechanisms of apigenin-an abundant, naturally-occurring plant flavonoid-with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
